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Background: Immortalized neuronal cell lines can be induced to differentiate into more mature neurons by adding
specific compounds or growth factors to the culture medium. This property makes neuronal cell lines attractive as
in vitro cell models to study neuronal functions and neurotoxicity. The clonal human neuroblastoma BE(2)-M17 cell
line is known to differentiate into a more prominent neuronal cell type by treatment with trans-retinoic acid.
However, there is a lack of information on the morphological and functional aspects of these differentiated cells.
Results: We studied the effects of trans-retinoic acid treatment on (a) some differentiation marker proteins, (b) types of
voltage-gated calcium (Ca2+) channels and (c) Ca2+-dependent neurotransmitter ([3H] glycine) release in cultured
BE(2)-M17 cells. Cells treated with 10 μM trans-retinoic acid (RA) for 72 hrs exhibited marked changes in
morphology to include neurite extensions; presence of P/Q, N and T-type voltage-gated Ca2+ channels; and
expression of neuron specific enolase (NSE), synaptosomal-associated protein 25 (SNAP-25), nicotinic
acetylcholine receptor α7 (nAChR-α7) and other neuronal markers. Moreover, retinoic acid treated cells had a
significant increase in evoked Ca2+-dependent neurotransmitter release capacity. In toxicity studies of the toxic
gas, phosgene (CG), that differentiation of M17 cells with RA was required to see the changes in intracellular free
Ca2+ concentrations following exposure to CG.
Conclusion: Taken together, retinoic acid treated cells had improved morphological features as well as neuronal
characteristics and functions; thus, these retinoic acid differentiated BE(2)-M17 cells may serve as a better
neuronal model to study neurobiology and/or neurotoxicity.
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Voltage-gated calcium channelsBackground
Neurotoxic chemicals, such as lead (Pb) and organophos-
phorus (OP) insecticides are prevalent in the environment.
The use of different in vitro cell culture assays for
predicting the in vivo effects of these chemicals have been
extensively reviewed in recent years and the issues
pertaining to their use have also been discussed [1-5]. The
in vitro systems have been developed and utilized not
only to understand the mechanisms of toxicity at the* Correspondence: radharaman.ray@us.army.mil
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reproduction in any medium, provided the ormolecular and cellular levels but also to screen potential
neurotoxicants. Potentially toxic compounds would be
candidates for in vivo testing. The objective of
neurotoxicologic studies on cells and tissues in vitro is to
characterize the cellular and molecular substrates and
pathways that contribute to impaired behavior, altered
function, or pathological changes in the whole animal fol-
lowing exposure to a toxicant [1]. The two main types of
cell culture systems used for in vitro neurological testing
are (a) primary neuronal cell cultures dissociated from
peripheral or central nervous system tissues and (b) clonal
cell lines derived from tumors of neurological origin [2].Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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neurochemical, and electrophysiological properties of
neurons in situ [2]. However, long-term culturing of pri-
mary neurons has been a major challenge. This creates
difficulties in addressing the fundamental questions
concerning cellular and molecular interactions among
the many functionally distinct neuronal cell types that
contribute to the development and functioning of the
mammalian central nervous system [6]. Neuroblastoma
cell lines have been used extensively as in vitro models
for studies on neuronal development, neurological dis-
eases and disorders as well as mechanisms of actions
and neurotoxicity of compounds affecting the nervous
system [2,7,8]. These in vitro models can provide a well-
controlled system in which to study many of the critical
cellular processes of neuronal development including
proliferation, differentiation, growth, and synaptogenesis.
Furthermore, cultured cell lines allow subtle changes in
cell number, morphology, and functions to be readily
detected compared to in vivo approaches and provide
reproducibility in test results as well as providing a
reduction in time, cost, and animal use [2,7].
Neuroblastoma cells can be differentiated by treatment
with chemical agents into distinct morphologic cell types.
These differentiated cells may be of different types: (a)
substrate-adherent (S), which resemble non-neuronal pre-
cursor cells; (b) a sympathoadrenal neuroblastic (N); or (c)
intermediate (I), which share elements of both S and N
types [9]. Each of these cell types differs in their ability to
induce a tumor. N-type cells are malignant, where as the
S-type cells are not; however, the I-type cells show the
greatest malignancy [10,11]. One common neuroblastoma
cell type used for in vitro research is BE(2)-M17, com-
monly known and henceforth called M17, which is avail-
able from ATCC.
M17 is a human neuroblastoma cell line cloned from
the SK-N-Be(2) neuroblastoma cell line isolated from a 2
year old male (ATCC, Manassas, VA). M17 cells are
multipotential with regard to neuronal enzyme expres-
sion e.g., choline acetyltransferase, acetylcholinesterase
and dopamine-β-hydroxylase implying cholinergic, dopa-
minergic and adrenergic properties. M17 cells convert
glutamate to GABA [12], however, this property is much
less than that exhibited by cerebellar cortex which con-
tains GABAergic neurons [13]. There has been a great
deal of research into differentiating the M17 cell line by
treatment with trans-retinoic acid (RA); this treatment
transformed the M17 cells to a morphologically distinct
phenotype, i.e., neuroblastic with neuritic processes and
with neurochemical characteristics [11,14]. This treat-
ment was the forerunner to the current clinical therapy
of neuroblastomas using isotretinoin. However, little
research has been performed on the functional changes
in M17 cells after exposure to RA.In the present study, we differentiated M17 cells by treat-
ment of cultures with 10 μM RA over a time period of 72
hours and investigated the morphological, neurochemical
and functional changes that occurred. We observed the
formation of neuronal processes and expression of proteins
(including neuron specific enolase (NSE), synaptic vesicle
associated protein – 25 kDa (SNAP-25), neurofilamentin
heavy chain (NF-H) and medium chain (NF-M), synapsin,
and nicotinic acetylcholine receptor alpha 7 (nAchR-α7);
moreover, we measured two functional parameters i.e.,
voltage-gated Ca2+ channel activity and stimulus-induced
Ca2+-dependent neurotransmitter ([3H] glycine) release. In
our and other laboratories, Ca2+-dependent [3H] glycine
release inhibition due neurotoxins (e.g. botulinum neuro-
toxins and tetanus toxin) has been shown to be a sensitive
indicator of toxicity in neuronal models such as cultured
primary mouse spinal cord cells [15-17] and synaptosomes
prepared from rat brain and spinal cord [18]. We have also
looked at the effects of RA differentiation on M17 cells
toxicity studies of the known toxicant, phosgene (CG,
COCl2). CG is a highly toxic chemical used in the manu-
facturing of pharmaceuticals, dyes, and polyfoam rubber
products. CG causes bronchoconstriction, vasoconstriction
and associated pathological effects that could be life threat-
ening and is reported to have a neural component involved
in its toxicity [19,20].
Methods
Cell culture
Frozen stock of the human neuroblastoma cell line, M17
(ATCC; Gaithersburg, MD), was cultured in 75 or 150
cm2 tissue culture flasks in a 1:1 mixture of Eagle’s Mini-
mum Essential Medium with non-essential amino acids
and F12 medium containing 10% fetal bovine serum
inside a humidified cell culture incubator with 95% air
plus 5% carbon dioxide according to company instruc-
tions to initiate the cultures. At 70-80% confluency, the
monolayer cells were sub-cultured in appropriate vessels
for use in experiments. When the cultures reached about
30% confluency, these cells were differentiated by treat-
ment with 10 μM retinoic acid (Sigma, St. Louis, MO)
added to the culture medium for 2 – 3 days or until they
reached the desired confluency.
Light microscopy
Cells were grown on coverslips to approximately 80%
confluency. Cell media was decanted and the cells
washed in 0.1 M sodium cacodylate buffer. The cells
were then fixed in buffered 1.6% formaldehyde and 2.5%
glutaraldehyde for 2–3 minutes at room temperature.
The fixed cells were rinsed in 0.1 M sodium cacodylate
buffer and stained with methylene blue in sodium borate
solution for 1–2 minutes. The stained cells were rinsed
with double distilled Millipore water. The cover slips
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The cells were viewed and photographed at a magnifica-
tion of 400X with an Olympus BX61 Microscope with
NIKON photo assembly Digital Site DS-L1.
Immunofluorescent staining
M17 cells were seeded onto 18 mm coverslips coated with
poly-D-lysine (Sigma Aldrich). At described times, cells
were fixed for 15 min in 3.7% formaldehyde, perme-
abilized with 0.1% saponin in PBS and blocked with 3%
BSA (PBSS). Primary antibodies against the neuron-
specific proteins β3-tubulin and synapsin-1/2 (Synaptic
Systems, Gottingen, Germany) were diluted 1:1000 in
PBSS and applied for 1 h at room temperature, followed
by Alexa-conjugated secondary antibodies (Invitrogen) di-
luted 1:500 in PBSS. Coverslips were mounted onto slides
with Prolong Gold DAPI (Invitrogen) and imaged using a
Zeiss LSM 700 confocal microscope. Z-stack images were
converted to a maximum projection image using Zen
2009 (Zeiss) software.
SDS-PAGE and western blotting to assess levels of
neuronal proteins
The level of neuronal proteins and SNAP-25 in M17 cells
was assessed by SDS-PAGE and Western blotting follow-
ing the method described by Ray et al. [21]. Briefly, cells
harvested in ice-cold physiological saline were lysed by in-
cubating with a lysis buffer containing 10 mM Tris–HCl,
150 mM NaCl, 1 mM EDTA, 1 mg/mL BSA, 1 mM PMSF,
1% Triton X-100 and protease inhibitors present in a pro-
tease inhibitor cocktail (cat. # P8340, Sigma, St. Louis,
MO) which was included throughout the wash and
solubilization steps to prevent protein degradation during
the assay. The lysates were cleared by centrifugation at
16,000 x g for 10 min and immediately analyzed by SDS-
PAGE. Each gel (8 – 16.5% acrylamide) lane was loaded
with approximately 30 μg protein, which was deter-
mined by bicinchoninic acid (BCA) protein assay. Dry
transfer to polyvinylidene fluoride (PVDF) membranes
was performed using the iBlot™ System (Invitrogen,
Carlsbad, CA) and blocked in 2% (w/v) bovine serum
albumin for 1 hr (this and all subsequent incubations
were performed in physiological saline, pH 7.5, room
temperature). To determine the protein levels of spe-
cific neuronal proteins, blots were probed with primary
antibodies overnight at 4°C. The primary antibodies in-
clude neuron specific enolase (NSE; N6049), SNAP-25
(59682), and vimentin (V2258), all purchased from Sigma
(St. Louis, MO); M1 muscarinic acetylcholine receptor
(M1 mAChR, AB5164), choline acetyltransferase (ChAT,
AB144P) from Cell Signaling (Boston, MA); synapsin
(AB1543), neurofilament medium (145kDa, AB1981), and
neurofilament heavy (200 kDa, AB1989) from Millipore
(Billerica, MA); and nicotinic acetylcholine receptor α7(nAChR-α7, ab23832, Abcam, Cambridge, MA). Anti-
bodies to β-Actin (4967) or GAPDH (2118), both from
Cell Signaling (Boston, MA), were used for normalization
to confirm equivalent gel loading. This was followed by
one hour incubation with a 1:1000 dilution of poly-
clonal peroxidase-conjugated anti-mouse IgG followed
by diaminobenzidine hydrogen peroxide (H2O2) and a
1:1000 dilution of appropriate peroxidase-conjugated
anti-rabbit IgG. Detection was performed by fluorescent
detection of enhanced chemifluorescent (ECF) substrate
(Amersham, NJ) on the Typhoon+ (GE Healthcare,
Piscataway, NJ). The relative amount of protein was
quantified by densitometric analysis using Image J program
(NIH public domain program, (http://rsbweb.nih.gov/ij/
index.html) and normalized against the respective house-
keeping protein (GAPDH or β-Actin) for each parameter
studied. To ensure equal loading of proteins on the gel,
each marker protein was normalized against a house-
keeping protein (GAPDH or β-Actin). The house-keeping
protein needed to be separate from the marker protein
on the gel. Differences in marker proteins in differenti-
ated vs. undifferentiated cells were assessed in terms of %
normalized optical density in differentiated cells compared
to undifferentiated (no RA) controls as shown in the table.
Normalized optical density of undifferentiated control was
100% for each type of marker protein.
Neurotransmitter release
High potassium-stimulated Ca2+-dependent neurotrans-
mitter release was determined as previously described [22].
Cultures were incubated with 2 μCi/mL [3H] glycine for 30
min at 37°C to label a releasable [3H] glycine pool. Cells
were then washed with a series of low K+ (3 mM)-
containing isotonic buffers (136 mM NaCl, 0–2 mM
CaCl2, 1 mM MgCl2, 10 mM HEPES, 10 mM glucose, and
0.1% BSA, ph 7.25, osmolarlity of 325 ± 5 mmol/kg). Un-
less otherwise indicated, [3H] glycine release was stimu-
lated by addition of 80 mM K+ and 2 mM Ca2+ to cultures;
stimulation medium was collected after 5 min at 37°C.
Calcium-dependent release was determined by subtracting
baseline radioactivity secreted from cultures in the absence
of Ca2+, and expressed as a percentage of the total cellular
radioactivity.
Radiolabeled 45Ca2+ uptake due to KCl depolarization
M17 cells were seeded into 24 well plates (Corning, Lowell,
MA) and cultured with 1 μCi/ml of [3H]-Valine (Perkin-
Elmer, Waltham, MA) for 24 hours. The medium was then
aspirated and cells were washed two times with 1 ml of a
physiological balanced solution (PBS) containing in mM:
128 NaCl, 5.9 KCl, 1.28 CaCl2, 1.2 MgCl2, 17 HEPES, 3.3
glucose. All components for this solution were obtained
from Sigma-Aldrich (St. Louis, MO). Cells were then incu-
bated with an additional 1 ml aliquot of PBS for one hour
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or stimulation medium containing 25 – 100 mM KCl
and 1 μCi/ml 45CaCl2. The different KCl concentrations
were adjusted by reducing the NaCl concentration pro-
portionately to maintain iso osmolality. The addition of
1 μCi/ml of 45CaCl2 did not significantly alter the
osmolality or the concentration of CaCl2 (data not
shown). After 4 minutes, the radioactive medium was
aspirated and ice-cold PBS was used to wash cells
twice. The cells were then lyzed by adding 0.4 N NaOH
solution and rocked overnight at 4°C. The next day, the
0.4N NaOH solution was pH neutralized with 0.4N
HCl + Tris. The neutralized solution was added to scin-
tillation fluid and 45Ca and 3H levels were measured on
a Beckman LS6500 multi-purpose scintillation counter
(Beckman-Coulter, Brea, CA). Calcium-dependent re-
lease was determined by subtracting baseline radio-
activity secreted from cultures in the absence of Ca2+,
and expressed as a percentage of the total cellular
radioactivity. Total cellular radioactivity was calculated
by adding the 45Ca2+ cpm released upon stimulation
with high KCl and the 45Ca2+ cpm present in the rest-
ing medium with low KCl before and after stimulation.
Direct Ca2+ uptake assay (Fluo-4 Direct™ assay kit)
The Ca2+ uptake assay kit (Fluo-4 Direct™, Invitrogen,
Carlsbad, California) contains a fluo-4 analog that pro-
duces a large fluorescence intensity increase in response
to Ca2+ binding with fluorescence excitation at 495 nm
and emission at 516 nm. The Fluo-4™ Direct Ca2+ Assay
kit was used according to the manufacturer’s instructions.
Briefly, 2X Fluo-4 Direct Ca2+ assay buffer (1M HEPES in
Hanks buffered saline solution, pH 7.3) was thawed and
mixed with 5 mM probenecid. The assay was conducted in
monolayer cultures. The 2X Fluo-4 Direct Ca2+ assay
buffer with 5 mM probenecid was added in equal vol-
ume to the sample volume and incubated at 37°C for
approximately one hour (Fluo-4 loading of cells). The
fluorescence (absolute units) was measured using the
SpectraMax Gemini EM (MDS Analytical Technologies,
Toronto, Canada) using excitation and emission wave-
lengths mentioned above.
Phosgene (CG) exposure
CULTEX air/liquid exposure system for either 12 mm or
24 mm culture filters was purchased from VetroCell
(Germany). Prior to exposure to CG, the cells grown on
these filters were transferred into the exposure device.
Cells were nourished by culture growth medium below the
filter membrane and exposed directly to either air (unex-
posed control samples) or air/CG (experimental samples)
without growth medium on top of the cells. The vapor ex-
posure system was moved to a chemical agent exposure
hood and exposed to CG by connecting to the inlet of theCULTEX system that ends on a hyperboloid-shaped air
distribution (trumpet) ensuring uniform exposure of the
aerosol on the surface of the cell culture [23-27]. The
outlet of the exposure system was passed through a
decontamination solution. After exposure to air or
CG, the cells were fed with fresh medium from the
upper side and free intracellular Ca2+ was monitored
by the Fluo-4 Direct Assay described above.
To assess intracellular free Ca2+ changes due to CG ex-
posure, undifferentiated or differentiated M17 cells were
first loaded with Fluo-4 and an initial fluorescence reading
was taken to record the basal Ca2+ level (i.e., the resting
intracellular Ca2+ levels without any treatment). The cells
were then exposed to either 0 ppm (air) or 16 ppm of CG
(in air) for 8 min at a flow rate of 8.13 ml/well/min. The
free intracellular Ca2+ changes were monitored directly
following exposure as a function of time.
Treatment with Ca2+ ionophore A23187
The Ca2+ Ionophore A23187 (Invitrogen, Carlsbad,
California) was prepared at stock concentration in DMSO
according to manufacturer’s instructions. Further dilutions
were prepared in M17 medium. A23187 was added directly
to M17 cells cultured in transwell inserts to obtained final
concentration of 5 μM. To assess intracellular free Ca2+,
the cells were first loaded with Fluo-4 prior to addition of
A23187 and the change in intracellular Ca2+ concentration
was measured directly following addition of A23187 using
Fluo-4 Direct Assay.
Results
Morphological changes and possible synaptic activity
To establish the conditions for RA treatment to induce cel-
lular differentiation, we examined the effects of different RA
concentrations (1, 5, and 10 μM) and times (48 – 120
hours). M17 cells transformed from an immature to a more
mature neuronal state after 72 hours of exposure to 10 μM
RA. Light photomicrographs of cells grown with or without
10 μM RA are shown in Figure 1. Undifferentiated cells had
a more rounded morphology with few neurites or apparent
synapses. Upon exposure to RA, the cells changed to a
neuron-like triangular shape. Some of these cells were
multinucleated with extended neurites. Treatment using less
than either 10 μM RA or 72 hrs did not produce the mor-
phological differentiation as shown as Figure 1 (data not
shown). Moreover, functional indicators of neuronal differ-
entiation as evidenced by immunofluorescence staining of
synaptic marker proteins or stimulated neurotransmitter
([3H] glycine) release described below were either not prom-
inent (morphology) or inconsistent (neuronal function) (data
not shown). The treatment conditions that we selected were
previously used to show early effects of RA-induced neur-
onal differentiation and oncogene (p26-Bcl-2) expression in
another BE(2) variant cell clone [28].
Figure 1 Morphology of M17 cells without and with RA
differentiation. M17 neuroblastoma cells were grown on cover slips
and treated with or without 10 μM RA for 72 hours to induce
differentiation. Cells were fixed, stained, and light microscopy
images were taken. (A) Undifferentiated cells, (B) Differentiated cells.
40X magnification; Scale bar is approximate.
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used immunofluorescence staining to compare expression
and localization of the pre-synaptic marker synapsin-1/2
and the early-stage neuron-specific marker β3-tubulin in un-
differentiated versus differentiated M17 cells. As was ob-
served using light microscopy (Figure 1), undifferentiated
M17 cells were characterized by a rounded morphology,
with few processes, and synapsin-1/2 and β3-tubulin were
distributed throughout the cell body (Figure 2A). By 72 h
after RA treatment (10 μM) some M17 cells had developed
a radial glial-like morphology with bilateral processes,
although compartmentalization of synapsin-1/2 and β3-
tubulin was not observed (Figure 2B). By 120 h differenti-
ated M17 cells exhibited extended processes with neuritic
morphologies (Figure 2C, D). Synapsin-1/2 and β3-tubulin
were observed to be diffusely present within the cell body
(supporting Additional file 1: Figure S1), but also exhibited
punctate localization along neurites (Figure 2C, D;
supporting Additional file 1: Figure S1). β3-tubulin and
synapsin-1/2 also exhibited distinct expression patterns
within the neurite growth cone, such that β3-tubulin was
concentrated along the neurite extension whereas synapsin-
1/2 accumulated within the growth cone tip (Figure 3).Expression of neuron specific proteins
The levels of expression of selected neuron specific pro-
teins were studied to help establish the degree of matur-
ation of M17 cells with and without 10 μM RA
treatment. Cultures of untreated and RA treated cells
were harvested and cell lysates were used for Western
blot analyses. The same lysates were used to detect NSE,
SNAP-25, synapsin, neurofilaments M and H, nAChR,
mAChR, and ChAT. The immunoreactictivity of selected
neuronal proteins are shown in Figure 4. Each specific
protein was identified by a single band marked at the ap-
propriate molecular weight. Band intensities were
quanitatively estimated and the results are shown as the
of % normalized optical density in differentiated cells
compared to undifferentiated (no RA) controls
(Figures 4D and 5D). The levels of SNAP-25 (Figure 4A),
synapsin (Figure 4B), and neurofilament M (data not
shown) showed an increase in differentiated vs. undiffer-
entiated cells. However, no neurofilament-light (NF-L) was
detected (data not shown). The level of nAChR α7
(Figure 5C) remained the same upon differentiation with
RA. Vimentin was expressed in undifferentiated cells but
decreased upon differentiation (Figure 4C). Neither un-
differentiated nor differentiated cells expressed any de-
tectable amount of ChAT (Figure 5A) and M1 mAChR
(Figure 5B). The specific antibodies used to detect ChAT
and M1 mAChR as described above under Methods posi-
tively identifies these proteins in rat brain tissue (Hoard-
Fruchey et al., unpublished results).
Neurotransmitter release
The effect of differentiation on functional neuroexocytosis
was assessed in M17 cells by measuring potassium stimu-
lated [3H] glycine release. Undifferentiated M17 cells had
a basal level of stimulated glycine release; this was sig-
nificantly increased in differentiated cells (Figure 6).
This increase in neurotransmitter release correlates with
the increase in the neuronal markers, particularly the
vesicular fusion protein, SNAP-25.
Expression of functional voltage-gated Ca 2+ channels
It is interesting to note that in M17 cells the increase in
45Ca2+ uptake due to increasing concentrations of KCl in
the incubation medium was very pronounced (five-fold) in
differentiated cells (Figure 7B); however, undifferentiated
cells had a small increase (Figure 7A). To characterize the
type of Ca2+ channels involved, 45Ca2+ uptake was mea-
sured in the absence and presence of known channel sub-
type specific antagonists. The antagonists were as follows:
NNC 55–0396 (Cav3.1 and 3.2); conotoxin GVIA (Cav2.2);
and agatoxin IVA (Cav2.1). The concentrations of the an-
tagonists used where according to published reports
[29-31]. The results (Figure 7C-E) showed a small
reduction in stimulated 45Ca2+ uptake due to NNC
Figure 2 Progressive development of neuronal morphologies induced by RA treatment. M17 neuroblastoma cells were grown on cover
slips. Cells were fixed, stained, and immunofluorescent images were taken (63X). β3-tubulin (red), synapsin-1/2 (green), and nuclei (blue).
Undifferentiated M17 cells (A), development of radial glia-like morphology 72 h after RA addition (B), neurite extension and network formation (C, D).
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observed due to conotoxin (1 mM) or agatoxin (300 nM).
These observations suggested functional Cav2.1 and 2.2
channels in differentiated cells.
Differentiated M17 cells as a model to study neurotoxicity
We hypothesized that the lack of expression of voltage-
gated Ca2+ channels in undifferentiated M17 cells limits
their use as neurotoxicity model. To test this hypothesis,
we studied the effect of a toxic industrial chemical, CG onFigure 3 Growth cone organization 120 h after RA treatment. M17 ne
and immunofluorescent images were taken (63X). Synapsin-1/2 (green), β3
localized to the neurite body, whereas synapsin-1/2 accumulates within theintracellular free Ca2+ concentration ([Ca2+]i) in both un-
differentiated and RA differentiated M17 cells. First, we
tested the effect of the non-specific Ca2+ ionophore
A23187 (5 μM) on [Ca2+]i. The results shown in Figure 8A
demonstrated a large increase in [Ca2+]i due to A23187 as
expect without any significant difference between undif-
ferentiated vs. differentiated cells. CG (16 ppm) caused
significant decreases (p<0.05) at all times tested only in
the RA differentiated cells without any effect in undiffer-
entiated cells (Figure 8B).uroblastoma cells were grown on cover slips. Cells were fixed, stained,
-tubulin (red) and nuclei (blue). β3-tubulin expression is predominantly
growth cone.
Figure 4 Expression of Neuron Specific Proteins in M17 cell
cultures. M17 neuroblastoma cells were grown and treated with or
without 10 μM RA for 72 hours to induce differentiation. The cells
were washed and solubilized in sample buffer and analyzed by
Western blotting for (A) SNAP-25, (B) synapsin, and (C) vimentin.
Either β-actin or GAPDH was used as a house keeping protein
marker to show equal protein loading of gels. The relative amount
of each marker protein was quantified by densitometric analysis
using Image J program (NIH public domain program, http://rsbweb.
nih.gov/ij/index.html). Differences in marker proteins in differentiated
vs. undifferentiated cells were assessed in terms of % normalized
optical density in differentiated cells compared to undifferentiated
(no RA) controls as shown in the bottom panel (D). Normalized
optical density of undifferentiated control was 100% for each type of
marker protein. **p<0.01, *p<0.05, using the student t test. n=6.
Figure 5 Expression of markers specific for cholinergic neurons.
M17 cells were grown without or with 10 μM RA for 72 hours to
induce differentiation. The cells were washed and solubilized in
sample buffer and analyzed by Western blotting for (A) choline
acetyltransferase (ChAT), (B) M1 muscarinic acetylcholine receptor
(mAcR), and (C) nicotinic acetylcholine receptor α 7 (nAcR a-7).
Either β-actin or GAPDH was used as a house keeping protein
marker to show equal protein loading of gels. The relative amount
of each marker protein was quantified by densitometric analysis
using Image J program (NIH public domain program, http://rsbweb.
nih.gov/ij/index.html). Differences in marker proteins in differentiated
vs. undifferentiated cells were assessed in terms of % normalized
optical density in differentiated cells compared to undifferentiated
(no RA) controls as shown in the bottom panel (D). Normalized
optical density of undifferentiated control was 100% for each type of
marker protein. ND = not detected and as such could not be
quantified. For M1 mAcR, the difference between undifferentiated vs
differentiated was not statistically significant (student t test). n=4.
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Neuronal cell models have been tested for their use in
predicting in vivo effects of different neurotoxic sub-
stances [1,2,4,5]. Attempts have been made to develop
and to utilize these in vitro neuronal models to study
the mechanisms of toxicity due to chemical and bio-
logical compounds at cellular and molecular levels.
Moreover, these models have also been tested for their
use in rapid screening of potential neurotoxicants out ofwhich positive compounds would be selected for in vivo
evaluation. Prior studies using in vitro cellular models
were intended to generate preliminary mechanistic and
toxicity information while reducing animal use and
Figure 6 Effect of 10 μM RA on K+-evoked [3H]-glycine release
in M17 cells. M17 neuroblastoma cells were grown and treated
with or without 10 μM RA for 72 hours to induce differentiation. The
treated M17 cells were then incubated with 2μCi/mL of [3H] glycine
for 30 min and then stimulated with 80 mM KCl. The % glycine
release/Total release was then calculated. ** Significantly different
from control on corresponding day after Student’s t-test (p<0.05).
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the three different types of in vitro cellular models pri-
marily used in biomedical research; (1) primary cell cul-
tures, (2) clonal cell lines, and (3) neural stem cells. The
main advantage of using primary cell cultures is that
they retain the morphological, neurochemical, and elec-
trophysiological properties of neurons in situ [2]. How-
ever, the disadvantages of primary cell cultures include
(a) a limited life span, (b) increased genetic variability
between model systems and cultures, (c) mixture of dif-
ferent neuronal populations in each preparation, as well
as (d) high resource requirements [2]. Neural stem cells
have the ability for self renewal and generating multiple
cell types representing different parts of the nervous
system; moreover, they can be derived from humans.
However, as with primary cultures, the stem cells require
animal use resulting in high resource requirements and
regulatory issues. After neural stem cells have reached
the end of their short variable life span, a new line has
to be generated and then characterized before use [2,32];
this is neither time nor cost effective.
A clonal cell line is defined as a population of cells that
originated from a single source and can be maintained in
culture for an extended period of time. A clonal cell culture
has a number of advantages that make them useful as
in vitro models: easy to obtain; relatively easy to grow; div-
ide rapidly; and can be continuously subcultured for a rela-
tively high number of passages to provide a large number
of cells in a short period of time [2]. The clonal M17
neuroblastoma cell line used in this study has the charac-
teristics described above as well as the ability to become
differentiated into a neuroblastic (N) cell when cultured in
the presence of RA for several days [11,14]. These proper-
ties make the M17 cell line a good in vitro cell model formechanistic and neurotoxicity testing. However, the func-
tional changes in M17 cells due to RA differentiation have
not been thoroughly characterized. A very relevant ques-
tion is why do we need a differentiated neuronal model for
neurobiology studies. The answer is that most of the neur-
onal functions such as membrane excitability, ion channels,
neurotransmitter release, endocyctotic and exocyctotic
events etc. are characteristics of mature neurons and can-
not be studied in an immature neuronal model.
Treatment with RA results in the progressive devel-
opment of neuronal morphologies and formation of
neuronal networks seen in a more mature neuronal
culture over time. A commonly measured characteristic
of differentiation is extension of neurites that are akin
to the axons and dendrites of fully differentiated neurons
[33]. These neuronal properties in RA differentiated
M17 cells were evidenced by both light microscopic
observations (Figure 1) and immunofluorescence staining
(Figure 2B - D). Although differentiated M17 cells dem-
onstrated evidence of maturing neuronal organization
and properties, the functional verification of synaptic
activity remains to be done.
Besides morphological characteristics, we also ob-
served differences in expression of several neuron spe-
cific proteins between undifferentiated and differentiated
M17 cells (Figure 4). The presence or levels of certain
proteins can vary between immature and mature neu-
rons. One such protein is neuron specific enolase (NSE)
which is responsible for generating phosphopyruvate
hydratase that participates in glycolosis/gluconeogenesis;
the levels of NSE increase as the neurons mature. While
undifferentiated M17 cells do express NSE, its level in-
creases due to differentiation. The formation of neurite-
like processes as a part of synaptic organization and
activity can be further characterized with the differential
expression of the neurofilament proteins, NF-M, and –H
that help form the neurofibrils within axons [33]. Devel-
oping neurons generally do not express either of these
neurofilament proteins until they become post-mitotic,
which is fairly late in development. Another neurofilament
subunit, vimentin, decreases as neurons mature [34]. We
were able to detect vimentin (Figure 4C) and the
neurofilament proteins -M as well as -H (data not shown).
We observed a decreased level of vimentin, whereas
neurofilaments H and M increased due to differentiation.
This might be an indication that under the conditions used,
M17 cells could be in an early stage of maturation. This hy-
pothesis is supported by the wide-spread expression of the
immature neuronal marker β3-tubulin and the accumulation
of synapsin-1/2 at the tip of the growth cone (Figure 3). The
presence of synapsin within the growth cone is consistent
with studies suggesting an axonogenic role during neurite
extension and branching, which is a early aspect of neuronal
maturation [35,36]. The levels and localization of these
Figure 7 Effect of 10 μM RA on the expression of functional voltage-sensitive. Ca2+ channels in M17 cells. M17 cells were treated with 1
mCi/ml 3H-Valine 24 hours prior to each experiment. M17 cells were either (A) undifferentiated cells stimulated for 4 minutes with KCL, or
differentiated cells (B) stimulated for 4 minutes with KCl, (C) KCl + 10 μM NNC 55-0396/KCl, (D) KCl + 1 mM w conotoxin, GVIA, or (E) KCl + 300
nM w agatoxin IVA. Each of these KCl solutions contained 1 mCi/ml of 45Ca2+. The ratio of 45Ca2+/3H was then used to calculate the percentage
difference of Ca2+ channel activity. % of control was calculated by dividing the experimental ratio of 45Ca2+/3H by the ratio of 45Ca2+/3H
generated with 5.9 mM KCl alone. n=4 *p<0.05 when compared to 5.9 mM KCl. **p<0.01 when compared to 5.9 mM KCl.
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change during prolonged culture in the presence of RA.
Since M17 cells are multipotential with regard to neur-
onal enzyme expression, we looked at the effects of RA
differentiation on the expression of the main isoforms of
acetylcholine (ACh) receptors (M1 mAChR, nAChR – α7)
and choline acetyltransferase (ChAT) to determine the
type of neurons that RA differentiated M17 cells could be.
In Figure 5, nAChR-α7 was the only one of the mentioned
proteins that was able to be detected. This indicates that
the RA differentiated M17 cells are not cholinergic but
would most likely be involved in post- and pre-synaptic
excitation in the brain and not post-ganglion nerves in the
CNS or exocrine glands [37,38].The differential expression of other neuronal proteins
than those previously described, expression of voltage-
gated Ca2+ channels and ionotropic receptors, which
ultimately lead to an increase in neurotransmitter
release, can be used to confirm neuronal characteristics
and neuroexocytosis. The presence of SNAP-25 and
synapsin are indicative of the potential to form function-
ing pre-synaptic compartments that mediate synaptic
vesicle fusion with the pre-synaptic membrane and
neurotransmitter release under depolarizing conditions.
Although immunoblot demonstrated that overall
synapsin expression in M17 cells does not significantly
change after differentiation with RA (Figure 4B),
synapsin-1/2 becomes distributed along processes, with
Figure 8 The effects of a Ca2+ ionophore and phosgene (CG)
on intracellular Ca2+ changes in differentiated vs.
undifferentiated M17 cells. M17 cells were cultured in Transwell
inserts without and with RA differentiation to 80% confluency. They
were then exposed to 5 μM Ca2+ ionophore, A23187 or 0 and 16
ppm CG. Intracellular free Ca2+ levels were monitored using Fluo-4
Ca2+ indicator assay. (A) Change in intracellular Ca2+ following
A23187 exposure (N=3); (B) Change in intracellular Ca2+ following
either 0 ppm (air) or 16 ppm CG exposure for 8 min (N=13). *p<0.05
when compared to treated (A23187 or CG) cells.
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itional file 1: Figure S1) and within the growth cone dur-
ing neuritogenesis (Figure 3). SNAP-25 is a major
component of the SNARE complex that is required for
the fusion of vesicle to the cell membrane for the exo-
cytosis of neurotransmitters. A two fold increase in the
level of SNAP-25 (Figure 4A) was observed. This in-
crease in SNAP-25 level may correlate with the signifi-
cant (p<0.01) increase in KCl stimulated [3H] glycine
release seen in differentiated M17 cells (Figure 6). The
increase in the stimulated release as shown in Figure 6
doesn’t look impressive; however, it is quite marked be-
cause we are comparing the fraction of the total pool of
[3H] glycine that is released in differentiated cells vs. un-
differentiated cells. As mentioned earlier, we studied
[3H] glycine release because this assay has been utilized
successfully in assessment of neurotoxicity in cell culture
models [15-18]. Others have studied glutamate release
and glutamate induced excitotoxicity in M17 cells [12]and as such these cells could be suitable to study glu-
tamate neurotoxicity. Since M17 cells have been
reported to have a poor GABAergic property [13] these
cells might not be a suitable model for GABA studies. In
this report we demonstrated that a representative neuro-
transmitter function is enhanced in differentiated M17
cells compared to immature cells.
For functional neuroexocytosis, neurons need both the
ability to form the SNARE complex and to have func-
tional voltage-gated Ca2+ channels. The ability of Ca2+
and other ions to move across the cell membrane is ne-
cessary for excitation and signal transmission between
neurons. Therefore, we studied the uptake of Ca2+ in
both undifferentiated and differentiated M17 cells. There
was no increase in the uptake of radiolabeled 45Ca2+
using varying concentrations of KCl in undifferentiated
M17 cells (Figure 7A); a strong increase in the uptake of
radiolabeled 45Ca2+ was observed with RA differentiation
of M17 cells with a maximum opening of voltage-gated
Ca2+ channels at 25 mM KCl. The presence of both N
and P/Q type Ca2+ channels was indicated by the 50 –
60% reduction in Ca2+ uptake when conotoxin GVIA
(N-type blocker) (Figure 7D) or agatoxin IVA (P/Q
blocker) (Figure 7E) were applied to the culture. Using
NNC 55–0396, only a small amount of T-type Ca2+
channels were detected (Figure 7C); however, the assay
may not be sensitive enough to pick up the small change
in intracellular Ca2+ concentration due to the small
unitary conductance of T-type Ca2+ channels. Since
neuroexocytosis is Ca2+ dependent, the lack of func-
tional voltage-gated Ca2+ channels in undifferentiated
M17 cells is detrimental for its use as a cell model for
neurotoxicity research. The treatment of M17 with RA
for a minimum of 72 hrs may be essential for functional
neuronal cultures. It has been postulated that neuronal
functions are cell maturation dependent [17].
In toxicity studies, it is important to look at both mor-
phological and functional changes to determine toxico-
logical mechanisms. It has been shown here as well as in
other studies that maturation of neuronal cultures is
very important when studying the effects of toxicants
[17]. It is known that intracellular Ca2+ is highly regu-
lated and involved in normal cell functions and in toxi-
cological mechanisms. The lack of voltage-gated Ca2+
channel expression in undifferentiated M17 cells could
limit their use as a neurotoxicity model. This is sup-
ported by our observation that differentiation of M17
cells with RA was required to see the changes in [Ca2+]i
following exposure to CG. The [Ca2+]i decrease due to
CG is a toxicant response in neuronal cells that can lead
to apoptosis and death of neurons [39,40]. Acquisition
in voltage-gated Ca2+ channels in differentiated neurons
may be a prerequisite for studying neurotoxicity due to
chemicals other than CG.
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The results reported here show that the human neuro-
blastoma BE(2)-M17 cells need to be treated with RA to
become differentiated into mature neurons and to ex-
hibit functional neuroexocytosis. Differentiation with RA
induces M17 cells to undergo morphological differenti-
ation and synaptic maturation. The apparent formation
of neural networks, the presence and function of SNARE
proteins and voltage-gated Ca2+ channels are necessary
for functional neuroexocytosis. Our results showing the
presence of these characteristics supports the use of dif-
ferentiated M17 cells as a cell model for neurobiology
and/or neurotoxicity research.
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Additional file 1: Figure S1. Split confocal image of synapsin-1/2 and
β3-tubulin expression in RA-induced M17 cells at 120 h. M17
neuroblastoma cells were grown on cover slips. Cells were fixed, stained,
and immunofluorescent images were taken (63X). Synapsin-1/2 (green),
β3-tubulin (red) and nuclei (blue). Split panels diffuse synapsin expression
in cell body; with punctuate expression apparent in elongated neurites.Abbreviations
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